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UNCERTAINTIES
Is tonsillectomy recommended in adults with recurrent
tonsillitis?
Jason Powell research fellow 1, James O’Hara consultant otolaryngologist, head and neck surgeon 2,
Sean Carrie consultant otolaryngologist, head and neck surgeon 3, Janet A Wilson professor of
otolaryngology, head and neck surgeon 2
1Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; 2Institute of Health & Society, Newcastle University, Newcastle
upon Tyne, UK; 3Freeman Hospital, Newcastle upon Tyne, UK
In many, tonsillitis is self-limiting and of relatively short
duration. A subset of patients suffers from recurrent debilitating
episodes, with impaired daily functioning and absence from
work.1 Adult tonsillitis places a substantial burden on healthcare
resources. Costs include primary care consultations, medical
treatment, hospital admissions, and treatment of potentially life
threatening complications.1-3 There are three approaches to the
management of tonsillitis: conservative (wait and watch),
antibiotics, or tonsillectomy. Tonsillectomy provides definitive
treatment for recurrent tonsillitis and was performed on more
than 17 000 adult patients in England in 2014-2015.4 Currently
there is uncertainty around the severity of disease at which it is
cost effective to perform tonsillectomy on adults with recurrent
tonsillitis, as compared with conservative management.
What is the evidence of uncertainty?
Search strategy and study selection
We searched Medline, Embase, and the Cochrane Library using
the terms “tonsillitis” or “tonsillectomy” or “pharyngitis.” We
included studies that involved adults and were published in
English between 1996 and February 2017 (table 1⇓). We found
Cochrane reviews comparing antibiotics with placebo, and
comparing tonsillectomy with watchful waiting. We also found
a review of qualitative outcomes in tonsillectomy, two
retrospective studies investigating complications of
tonsillectomy, a cross-sectional study of the complications of
tonsillitis and tonsillectomy rates, and a small cohort study
observing economic outcomes pre and post tonsillectomy.
In the UK, Clinical Commissioning Groups have labelled
tonsillectomy as a “relatively ineffective intervention.”2 Since
the CCG reports were published, a subsequent change in
attitudes towards surgery has led to a steep decline in the rates
of tonsillectomies in recent years.2 10 This reduction in the
number of operations has, however, been paralleled by a
substantial rise in admissions for tonsillitis and its
complications.2 In this article, we present evidence on the
effectiveness of antibiotics and of tonsillectomy, and also the
associated costs and complications.
Antibiotics
Antibiotics are frequently prescribed for tonsillitis in primary
care.1 A recent Cochrane systematic review of 27 trials (12 835
cases of sore throat) showed that, at day three of the illness,
antibiotics reduced symptoms of sore throat, (risk ratio 0.68;
95% confidence interval 0.59 to 0.79). The incidence of
peritonsillar abscess was reduced in comparison with the placebo
group (risk ratio 0.15, 95% confidence interval 0.05 to 0.47).5
The ability to draw on these findings is limited by the lack of
subgroup analysis of tonsillitis in the sore throat cases. Further,
these modest benefits have to be balanced against side effects,
the emergence of antibacterial resistance, and costs.
Tonsillectomy
Benefits
A Cochrane review6 published in 2014 identified two
randomised controlled trials from Finland comparing
tonsillectomy and watchful waiting in adults. The studies did
not report on antibiotic use. There were 3.6 fewer (95%
confidence interval 7.9 to 0.70 more) episodes of sore throat
within six months of surgery, equating to 10.6 fewer sore throat
days (95% confidence interval 5.8 to 15.8). Absenteeism in the
surgery arm was not substantially reduced (3.3 days, 95%
confidence interval −7.7 to 1.1). Limitations included the short
duration of follow-up, statistical heterogeneity, and omission
of most postoperative complications from the analysis.
A systematic review concerning the impact of adult
tonsillectomy on quality of life outcomes identified eight
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What you need to know
• Increasing rates of adult tonsillitis affect quality of life for patients and put pressure on health services through repeated primary care
consultations and hospital admissions with complications
• Tonsillectomy is safe and effective to prevent recurrent tonsillitis; however, there is uncertainty over the stage of disease at which the
operation is cost effective
• Discuss the options of watchful waiting, antibiotics, and tonsillectomy with patients experiencing recurrent tonsillitis, and explain the
risks, benefits, and costs of each
retrospective cohort studies (708 pooled participants). Several
studies reported low response rates (<50%). Outcome measures
included generic (short form survey) and specific postsurgical
quality of life measures (Glasgow Benefit Inventory).
Tonsillectomy was considered likely to improve overall quality
of life, particularly patients’ physical and general health.7
Costs
The direct healthcare costs of an adult tonsillectomy are reflected
in the procedure tariff: £1079 in the UK, $3832 in the United
States.8 Tonsillectomy is a painful procedure that requires an
average of 14 days off work,11 with associated costs of lost
productivity. Only one small US study (83 adults) assessed the
overall economic impact of adult tonsillectomy; it showed a
breakeven point of 2.3 years after the procedure through reduced
costs, both medical and work related, of tonsillitis.3
Additionally, patients can suffer complications following
tonsillectomy. The commonest adverse event is postoperative
haemorrhage, which can require re-operation. A review of
complications of adult tonsillectomy from the two largest and
most recent North American cohort studies (collectively 42 000
operations) showed a postoperative haemorrhage rate of 6.37%
(2308/36 210),8 re-operation rates for haemorrhage of 1.54%
(558/36 210)8 and 3.2% (189/5968),9 and a mortality rate of
0.03% (2/5968).9 The total healthcare costs escalated to an added
60% in the case of re-operation.8
Healthcare providers should also consider the costs of recurrent
tonsillitis and complications if a conservative approach is
adopted. A study extracted English Hospital Episode statistics
all age data and showed that the overall tonsillectomy rate fell
from 159 per 100 000 in 1991 to 89 per 100 000 in 2011 (44%
reduction), while the contemporaneous admissions for tonsillitis,
peritonsillar abscess, and retro or parapharyngeal abscess rose
by 310% (94 per 100 000), 31% (3 per 100 000), and 39% (2
per 100 000), respectively. The use of bed day occupancy as a
surrogate for cost implied that the rising rates for sore throat
related admissions negated the savings from the decline in
tonsillectomy over the decade.2
Is ongoing research likely to provide
relevant evidence?
We searched the Current Controlled Trials Register, the
metaRegister of Controlled Trials, and the US Government
Clinical Trials Register on 7 February 2017 using the search
terms “tonsillitis” or “pharyngitis” or “tonsillectomy.” We found
one multicentre randomised controlled trial that is currently
recruiting patients and is expected to complete in 2019. The
National Trial of Tonsillectomy In Adults in the UK (UKCRN
ID 17530, www.NATTINA.com)12 aims to assess the clinical
and cost effectiveness of tonsillectomy compared with
conservative management (deferred surgery) in 510 adult
participants with recurrent tonsillitis. The primary outcome
measure is the number of sore throat days over a 24 month
period.
What should we do in light of the
uncertainty?
The label of a “relatively ineffective intervention” has
undoubtedly affected referrals for tonsillectomy. Recent
qualitative work demonstrates that general practitioners feel
pressured to reduce tonsillectomy referral rates and that many
patients perceive a barrier to the treatment they desire.10
New UK guidelines from the Royal College of Surgeons of
England for adult tonsillectomy were published in 201613 but
are essentially unchanged since the 2010 Scottish Intercollegiate
Guidelines Network guidelines, as no further evidence is
available (box 1). The referral guideline for surgery on the basis
of the frequency and duration of recurrent sore throats only
extrapolates from childhood evidence, and evidence is needed
on clinical and cost effectiveness in adults.14
Assess patients for the frequency of episodes and severity of
symptoms and their impact on quality of life. Discuss potential
risks and likely benefits of either approach to enable making a
shared decision (table 2⇓).
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Box 1: Recommended indications for consideration of tonsillectomy for recurrent acute sore throat in adults,
based on Scottish Intercollegiate Guidelines Network (SIGN) guidelines
Sore throats are due to acute tonsillitis
The episodes of sore throat are disabling and prevent normal functioning
Seven or more well documented, clinically significant, adequately treated sore throats in the preceding year, or
five or more such episodes in each of the preceding two years, or
three or more such episodes in each of the preceding three years.
Recommendations for future research
Study design: Randomised controlled trial
Population: Adults with recurrent tonsillitis
Intervention: Tonsillectomy
Comparison: Deferred surgery (watchful waiting), with consideration of antibiotics in acute episodes only
Outcome:
1) Full clinical evaluation, including complications, patient reported outcome measures of sore throat and quality of life
2) Cost based economic evaluation, including lost productivity and healthcare associated costs
What patients need to know
• If you have repeated episodes of sore throat or tonsillitis, share with your doctor about the severity of symptoms and how they affect
your work and life.
• For most people tonsillitis will resolve with no need for medications or surgery. Your doctor might advise waiting for a period of time
as symptoms improve spontaneously, or they might recommend antibiotics if your symptoms are severe.
• Tonsillectomy might be considered if you have several episodes of tonsillitis in a year and they affect your daily functioning.
• Tonsillectomy is effective in reducing episodes of sore throat. However the surgery is associated with complications and costs. Discuss
these with your doctor to decide your preferred approach.
Education into practice
• Do you routinely ask your patient about the effect of symptoms of tonsillitis on their life and work?
• Have your compared your own tonsillectomy referral practice with other practitioners?
How patients were involved in the creation of this article
We discussed an early draft of this paper with three patients with tonsillitis. They stressed the importance of considering the severity of
tonsillitis episodes and their impact on their life and work. With their comments we highlighted the impact of tonsillitis on quality of life.
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Tables
Table 1| Summary of evidence for the treatment of recurrent adult tonsillitis
Summary statement on
quality of evidence
ResultsComparatorInterventionParticipantsStudy design
Antibiotics
High quality evidenceSymptoms of sore throat at day 3 of illness
reduced with antibiotics, risk ratio 0.68 (95%
confidence interval 0.59 to 0.79)
Incidence of peritonsillar abscess reduced, risk
ratio 0.15 (95% confidence interval 0.05 to 0.47)
PlaceboAntibiotics12 835 cases of sore
throat in children and
adults
Systematic review and
meta-analysis (27
randomised controlled trials)5
Tonsillectomy
Low quality evidence3.6 fewer (95% confidence interval 7.9-0.70
more) episodes of sore throat within six months
of surgery
Watchful waitingTonsillectomy156 adultsSystematic review and
meta-analysis (2 randomised
controlled trials)6
Low quality evidenceImprovement in quality of life questionnaire
scores postoperatively
Pre to
postoperative
Tonsillectomy708 adultsSystematic review (8 cohort
studies)7
Low quality evidenceReduction in tonsillectomy rates and a
contemporaneous increase in admission for the
complications of tonsillitis
NoneNoneAdults and children in
England
Cross-sectional study 2
Low quality evidenceBreakeven point of surgical costs 2.3 years after
the procedure through reduced medical and work
related costs of tonsillitis
Pre to
postoperative
Tonsillectomy83 adultsCohort study3
High quality evidence6.37% postoperative haemorrhage rate
1.54% re-operation rates for haemorrhage
NoneTonsillectomy36 210 adultsRetrospective study8
High quality evidence3.2% re-operation rates for haemorrhage
0.03% mortality rate
NoneTonsillectomy5968 adultsRetrospective study9
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Table 2| What to do in light of the uncertainty
RecommendationClinical group
Evidence supports the benefit of tonsillectomy over watchful waitingAdults meeting SIGN criteria for the number of episodes of tonsillitis (see box
1)
Explain the lack of certainty about benefit of tonsillectomy over watchful waiting,
guiding the patient in making a decision
Adults not meeting SIGN criteria, but who have a high symptom burden
Watchful waiting with consideration of antibiotics in acute episodesAdults not meeting SIGN criteria with minimal symptom burden
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